Company news

Zelira Therapeutics Ltd. news in 2019

Zelira Therapeutics Ltd.'s news releases, calls and decks from 2019, newest first.

View company

Zelira Therapeutics expands HOPE distribution in the U.S.A

December 3, 2019

Ilera Therapeutics Merger Completed and Board Changes

December 1, 2019

Agreement with Health House to Distribute Zelda Products

November 20, 2019

Formulations to be supplied as part of CARE NSW trial

November 13, 2019

Zeldas Phase II Insomnia Clinical Trial Fully Enrolled

November 6, 2019

September 2019 Quarterly Report

October 31, 2019

Zelda to merge with US-based Ilera Therapeutics

October 8, 2019

Zeldas Autism Observational Study Recruits 100th Participant

August 21, 2019

June 2019 Quarterly Report

July 31, 2019

Zelda Collaborates with Emerald Clinics

July 18, 2019

Response to ASX Price and Volume Query

July 11, 2019

Zelda Granted Approval for Opioid Reduction Trial

July 1, 2019

March 2019 Quarterly Report

April 29, 2019

Zelda Partners with Ilera HealthCare

March 11, 2019

Aus Patent For Novel Prognostic Marker for Breast Cancer

March 5, 2019

Appendix 4D & FY19 Interim Financial Report

February 22, 2019

December 2018 Quarterly Report and Board Transition

January 30, 2019

Decks in 2019